<DOC>
	<DOCNO>NCT01010191</DOCNO>
	<brief_summary>Irritable bowel syndrome patient give either placebo pill treatment period 3 week .</brief_summary>
	<brief_title>Harnessing Placebo Effects : Non-Deceptive Use Placebo Irritable Bowel Syndrome ( IBS )</brief_title>
	<detailed_description>Seventy patient irritable bowel syndrome ( IBS ) randomize either 1 ) placebo pill 2 ) treatment follow 3 week . The study involve three visit : baseline , midpoint end point . At baseline patient physical examination , evaluate IBS administer standardized IBS questionnaire include : `` IBS adequate relief '' questionnaire , IBS global symptom improvement scale , IBS quality life IBS symptom severity scale . At midpoint endpoint questionnaire administer . Patients treatment offer education manage IBS end study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Irritable bowel syndrome . Any sign organic bowel disease rectal bleeding . No major illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>irritable bowel syndrome</keyword>
	<keyword>organic digestive disease</keyword>
</DOC>